KRAS and neoplasm: Future research should focus on the following key areas: enhancing the effectiveness of pCR and personalized treatment, investigating the impact of KRAS mutations and their associated signaling pathways on tumor biology, exploring the mechanisms of EGFR mutations and their signaling pathways, and optimizing perioperative treatment models.